Christopher A. Kroeger, M.D.

Christopher A. Kroeger, M.D.

President and Chief Executive OfficeratMapLight Therapeutics· In proxies 2024–2025

Pay in FY2025+192% from the year before

Christopher A. Kroeger, M.D. was paid $25.6M in FY2025 (Dec), up 192%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each MapLight Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MapLight TherapeuticsPublic company · 2 yr
    • President and Chief Executive Officer2024 – Present · 2 yrStock in role -56%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?